Global Blood Therapeutics wins first FDA approval with sickle cell disease med
The drugmaker says its drug, Oxbryta, can be used in combination with Novartis ’s drug, Adakveo, which nabbed FDA approval just last week
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Sickle Cell Anemia